The Optimal Duration of Endocrine Therapy in Hormone Receptor-Positive Breast Cancer

被引：0
|
作者：
Sledge, George W., Jr. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Med, Palo Alto, CA 94304 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：383 / 404
页数：4
相关论文
共 50 条
  • [1] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
    Tevaarwerk, Amye J.
    Wisinski, Kari B.
    O'Regan, Ruth M.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
  • [2] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
    Tung, Nadine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
  • [3] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    [J]. Current Oncology Reports, 2023, 25 : 689 - 698
  • [4] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
  • [5] Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer
    Symonds, Lynn K.
    Davidson, Nancy E.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11) : 1240 - 1242
  • [6] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian Li
    Xu Feng-Rui
    Jiang Ze-Fei
    [J]. 中华医学杂志(英文版), 2020, 133 (19) : 2338 - 2345
  • [7] Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
    Bian, Li
    Xu, Feng-Rui
    Jiang, Ze-Fei
    [J]. CHINESE MEDICAL JOURNAL, 2020, 133 (19) : 2338 - 2345
  • [8] Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis
    Chen, Juan
    Zhang, Xiaohui
    Lu, Yan
    Zhang, Ting
    Ouyang, Zhaolian
    Sun, Qiang
    [J]. BREAST CANCER, 2021, 28 (03) : 630 - 643
  • [9] Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis
    Juan Chen
    Xiaohui Zhang
    Yan Lu
    Ting Zhang
    Zhaolian Ouyang
    Qiang Sun
    [J]. Breast Cancer, 2021, 28 : 630 - 643
  • [10] Extended Adjuvant Endocrine Therapy in Hormone Receptor-Positive Early Breast Cancer
    Bracken-Clarke, Dara B.
    Lucas, Mairi W.
    Higgins, Michaela J.
    [J]. BREAST CARE, 2017, 12 (03) : 138 - 144
12345